Clinical Trials
2 trialsNCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03728543 2018-11-02
the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2/3 Unknown